Rituximab in Pemphigus Foliaceous With Autoantibodies Against Both Desmoglein 1 and Desmoglein 3

Carvalho, RMaio, PCunha, DFreitas, IAfonso, ACardoso, J2015-10-162015-10-162011Eur J Dermatol. 2011 May-Jun;21(3):415-6http://hdl.handle.net/10400.17/2310engHCC DERHCC PAT CLINAntibodies, Monoclonal, Murine-Derived/therapeutic useAntigens, CD20Autoantibodies/immunologyDesmoglein 1/immunologyDesmoglein 3/immunologyFollow-Up StudiesImmunologic Factors/therapeutic usePemphigus/drug therapyPemphigus/immunologyRituximab in Pemphigus Foliaceous With Autoantibodies Against Both Desmoglein 1 and Desmoglein 3other10.1684/ejd.2011.1288